» Articles » PMID: 32829411

The Distribution and Spread of Susceptible and Resistant Neisseria Gonorrhoeae Across Demographic Groups in a Major Metropolitan Center

Overview
Journal Clin Infect Dis
Date 2020 Aug 24
PMID 32829411
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Genomic epidemiology studies of gonorrhea in the United States have primarily focused on national surveillance for antibiotic resistance, and patterns of local transmission between demographic groups of resistant and susceptible strains are unknown.

Methods: We analyzed a convenience sample of genome sequences, antibiotic susceptibility, and patient data from 897 gonococcal isolates cultured at the New York City (NYC) Public Health Laboratory from NYC Department of Health and Mental Hygiene (DOHMH) Sexual Health Clinic (SHC) patients, primarily in 2012-2013. We reconstructed the gonococcal phylogeny, defined transmission clusters using a 10 nonrecombinant single nucleotide polymorphism threshold, tested for clustering of demographic groups, and placed NYC isolates in a global phylogenetic context.

Results: The NYC gonococcal phylogeny reflected global diversity with isolates from 22/23 of the prevalent global lineages (96%). Isolates clustered on the phylogeny by patient sexual behavior (P < .001) and race/ethnicity (P < .001). Minimum inhibitory concentrations were higher across antibiotics in isolates from men who have sex with men compared to heterosexuals (P < .001) and white heterosexuals compared to black heterosexuals (P < .01). In our dataset, all large transmission clusters (≥10 samples) of N. gonorrhoeae were susceptible to ciprofloxacin, ceftriaxone, and azithromycin, and comprised isolates from patients across demographic groups.

Conclusions: All large transmission clusters were susceptible to gonorrhea therapies, suggesting that resistance to empiric therapy was not a main driver of spread, even as risk for resistance varied across demographic groups. Further study of local transmission networks is needed to identify drivers of transmission.

Citing Articles

Exploring SNP filtering strategies: the influence of strict vs soft core.

Taouk M, Featherstone L, Taiaroa G, Seemann T, Ingle D, Stinear T Microb Genom. 2025; 11(1.

PMID: 39812553 PMC: 11734701. DOI: 10.1099/mgen.0.001346.


Leveraging local public health to advance antimicrobial stewardship (AMS) implementation and mitigate antimicrobial resistance (AMR): a scoping review.

Leung V, Ashiru-Oredope D, Hicks L, Kabbani S, Aloosh M, Armstrong I JAC Antimicrob Resist. 2024; 6(6):dlae187.

PMID: 39698503 PMC: 11651725. DOI: 10.1093/jacamr/dlae187.


Navigating the network: a narrative overview of AMR surveillance and data flow in the United States.

Robillard D, Sundermann A, Raux B, Prinzi A Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e55.

PMID: 38655022 PMC: 11036423. DOI: 10.1017/ash.2024.64.


Gonorrhoea on the rise in Denmark since 2022: distinct clones drive increase in heterosexual individuals.

Pedersen T, Wessman M, Lindegaard M, Hallstrom S, Westergaard C, Brock I Euro Surveill. 2024; 29(7).

PMID: 38362625 PMC: 10986658. DOI: 10.2807/1560-7917.ES.2024.29.7.2400059.


The Gonococcal Genetic Island defines distinct sub-populations of .

Youngblom M, Shockey A, Callaghan M, Dillard J, Pepperell C Microb Genom. 2023; 9(5).

PMID: 37213168 PMC: 10272882. DOI: 10.1099/mgen.0.000985.


References
1.
Eyre D, Sanderson N, Lord E, Regisford-Reimmer N, Chau K, Barker L . Gonorrhoea treatment failure caused by a strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Euro Surveill. 2018; 23(27). PMC: 6152157. DOI: 10.2807/1560-7917.ES.2018.23.27.1800323. View

2.
Bauer H, Mark K, Samuel M, Wang S, Weismuller P, Moore D . Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003. Clin Infect Dis. 2005; 41(6):795-803. DOI: 10.1086/432801. View

3.
Chung G, Yoo J, Oh H, Lee Y, Cha S, Kim S . Complete genome sequence of Neisseria gonorrhoeae NCCP11945. J Bacteriol. 2008; 190(17):6035-6. PMC: 2519540. DOI: 10.1128/JB.00566-08. View

4.
Lee R, Seemann T, Heffernan H, Kwong J, Goncalves da Silva A, Carter G . Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand. J Antimicrob Chemother. 2017; 73(2):353-364. PMC: 5890773. DOI: 10.1093/jac/dkx405. View

5.
Grad Y, Kirkcaldy R, Trees D, Dordel J, Harris S, Goldstein E . Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study. Lancet Infect Dis. 2014; 14(3):220-6. PMC: 4030102. DOI: 10.1016/S1473-3099(13)70693-5. View